Home / Knowledge Centre /
Case study

Harnessing effective cold chain capability to absorb the impact of mid-study protocol changes

The most successful clinical trials have one thing in common: sponsors never stop looking for ways to improve processes that support the core objective of delivering safe, compliant investigational product to patients, when and where they need it.

This was the case for one pharmaceutical company, who was working to refine its trial drug formula from frozen liquid form to lyophilised powder without disrupting its global, phase II study. Read our latest case study to learn how Almac helped the sponsor effectively manage the drug formulation change mid-trial without study interruptions or patient impact.

View Resource
Almac Logo

Almac Clinical Services

Guided by our extensive clinical supply experience and expertise, Almac Clinical Services  is  recognised as an innovative,  global solution provider within the specialised and complex market of clinical trial supply.

Our integrated and adaptable solutions offer the most flexible approach to support the delivery of global clinical trials from protocol right through to patient delivery.

Our core purpose is to be the partner of choice, to deliver the next generation of health care solutions effectively and to focus on winning for you and your patients.

Learn More

Download here instantly

This website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies